Obstacles to the early detection of endocervical adenocarcinoma

International Journal of Gynecological Pathology

Volumn 24, Issue 4, 2005, Pages 399-403

  Kalir, T ^a   Simsir, A ^b   Demopoulos, H B ^b   Demopoulos, Rita I ^b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Adenocarcinoma; Endocervical; In situ; Pap smear; Transformation zone

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; EARLY DIAGNOSIS; ENDOPHYTIC GROWTH; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; TRANSFORMATION ZONE; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; UTERINE ENDOCERVIX;

ADENOCARCINOMA; BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 25444443620     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000170067.73452.72     Document Type: Article

References (20)

1. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In: RJ Kurman, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York: Springer-Verlag, 2002:349-50.
2. Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-44.
3. Lee KR, Flynn CE. Early invasive adenocarcinoma of the cervix. Cancer 2000;89:1048-55.
4. Krane JF, Granter SR, Trask CE, et al. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer 2001;93:8-15.
5. Boon ME, Ouwerkerk-Noordam E, Van Leeuwen AW, et al. How to improve cytologic screening for endocervical adenocarcinoma? Eur J Gynaecol Oncol 2002;23:481-5.
6. Scheiden R, Wagener C, Knolle U, et al. Atypical glandular cells in conventional cervical smears: incidence and follow-up. BMC Cancer 2004;4:37.
7. Simsir A, Hwang S, Cangiarella J, et al. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin. Cancer 2003;99:323-30.
8. Segal A, Frost FA, Miranda A, et al. Predictive value of diagnoses of endocervical glandular abnormalities in cervical smears. Pathology 2003;35:198-203.
9. Jeng CJ, Liang HS, Wang TY, et al. Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening. Int J Gynecol Cancer 2003;13:518-21.
10. Mathers ME, Johnson SJ, Wadehra V. How predictive is a cervical smear suggesting glandular neoplasia? Cytopathology 2002;13:83-91.
11. Valdini A, Vaccaro C, Pechinsky G, et al. Incidence and evaluation of an AGUS Papanicolaou smear in primary care. J Am Board Fam Pract 2001;14:172-7.
12. Jacobson RG, Lapinski RH, Kalir T. The clinical importance of atypical glandular cells of undetermined significance on the cytologic smear. Prim Care Update Ob Gyns 2000;7:250-2.
13. Sindos M, Pisal N, Freeman-Wang T, et al. Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival. Obstet Gynecol 2003;101:1354-5.
14. Thomas DB, Ray RM. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol 1996;144:281-9.
15. Lacey JV Jr, Brinton LA, Abbas FM, et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 1999;8:1079-85.
16. Muskhelishvili L, Thompson PA, Kusewitt DF, et al. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. J Histochem Cytochem 2001;49:229-36.
17. Sasaki M, Kaneuchi M, Fujimoto S, et al. CYP1B1 gene in endometrial cancer. Mol Cell Endocrinol 2003;202:171-6.
18. McFadyen MC, Cruickshank ME, Miller ID, et al. Cytochrome P450 CYP 1B1 over-expression in primary and metastatic ovarian cancer. Br J Cancer 2001;85:242-6.
19. Seacat AM, Kuppusamy P, Zweier JL, et al. ESR identification of free radicals formed from the oxidation of catechol estrogens by Cu2+. Arch Biochem Biophys 1997;347:45-52.
20. Tsuchiya Y, Nakajima M, Kyo S, et al. Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 2004;64:3119-25.